Copyright
©The Author(s) 2015.
World J Hepatol. Jun 28, 2015; 7(12): 1685-1693
Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1685
Published online Jun 28, 2015. doi: 10.4254/wjh.v7.i12.1685
Table 2 Changes in the urine volume and osmolality after administration of tolvaptan
| TLV group (n = 60) | |
| 24 h urine volume (mL) | 1844 (1200-2400) |
| 24 h water intake (mL) | 1231 (894-1463) |
| Pre-urine osmolality (OSM) | 417 (366-487) |
| Time to achieve the minimum urine osmolality (d) | 7 (2-6) |
| The minimum urine osmolality (OSM) | 274 (230-311) |
| Pre-post-urine osmolality rate (%) | 66 (55-79) |
- Citation: Ohki T, Sato K, Yamada T, Yamagami M, Ito D, Kawanishi K, Kojima K, Seki M, Toda N, Tagawa K. Efficacy of tolvaptan in patients with refractory ascites in a clinical setting. World J Hepatol 2015; 7(12): 1685-1693
- URL: https://www.wjgnet.com/1948-5182/full/v7/i12/1685.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i12.1685